Skip to Content

Jeffrey A. Meckler

Jeffrey A. Meckler

CEO and Vice Chairman of the Board
Mr. Meckler joined our Board in April 2017 as Vice Chairman and was appointed Chief Executive Officer in July 2017. Mr. Meckler brings more than 25 years of financial and healthcare experience, having held a variety of senior leadership roles in both large and small biopharma companies. Mr. Meckler started his career in life sciences at Pfizer, Inc. During his 17 years at Pfizer, Mr. Meckler rose through a series of positions eventually becoming a member of the Corporate Finance Leadership Team overseeing a number of acquisition and divestitures. Most recently, Mr. Meckler was the CEO of Cocrystal Pharma, transforming it from a research company into a clinical and development company. Additionally, Mr. Meckler led QLT, Inc., Cypress Bioscience, Inc. and Retrophin, Inc. through transformational times. Mr. Meckler has served on the board of a number of private and public companies and is currently a director and former Chairman of Retrophin. Mr. Meckler holds a B.S. in Industrial Management and a M.S. in Industrial Administration from the Tepper School of Business at Carnegie Mellon University. Additionally, he received his J.D. from Fordham University’s School of Law.